The company has received final approval from the United States Food
and Drug Administration (USFDA) to market Baclofen tablets in the
strength of 5 mg, Zydus Cadila said in a statement. The product will
be manufactured at the group's formulations manufacturing facility at
Baddi, it added.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-to-market-muscle-spasms-tablets/articleshow/75218041.cms
Saturday, April 18, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment